Fund HoldingsSands Capital Alternatives, LLC

Total Portfolio Value
$459.73M
Total Bought
$111.10M
Total Sold
$51.23M
Net Transaction
+$59.87M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
INHIBIKASE THERAPEUTICS INC010,950,000+10,950,000035,5887.74%+35,588
COUPANG INC(CPNG)11,931924,712+912,78129320,3254.42%+20,032
KLAVIYO INC(KVYO)3,515,3253,470,694-44,631124,372143,13131.13%+18,759
DATADOG INC(DDOG)1,40697,788+96,38216213,9733.04%+13,811
MONDAY COM LTD
SHS
048,278+48,278011,3672.47%+11,367
SAMSARA INC(IOT)3,172198,690+195,5181538,6811.89%+8,528
TOAST INC(TOST)4,453231,530+227,0771268,4391.84%+8,313
DOORDASH INC(DASH)423,338407,343-15,99560,42368,33214.86%+7,909
CROWDSTRIKE HLDGS INC(CRWD)22117,100+16,879625,8511.27%+5,789
UIPATH INC(PATH)1,155,2461,584,677+429,43114,78720,1414.38%+5,354
TARSUS PHARMACEUTICALS INC(TARS)170,000170,00005,5919,4132.05%+3,822
CANDEL THERAPEUTICS INC405,837405,83702,8123,5230.77%+710
GITLAB INC(GTLB)6580-658340-34
SPRUCE BIOSCIENCES INC787,007715,817-71,1903703010.07%-69
TAYSHA GENE THERAPIES INC(TSHA)724,873724,87301,4571,2540.27%-203
908 DEVICES INC237,258237,25808235220.11%-301
ACRIVON THERAPEUTICS INC2,122,6052,122,605014,85812,7782.78%-2,080
NU HLDGS LTD(NU)5,498,8027,021,159+1,522,35775,05972,73915.82%-2,319
ACUMEN PHARMACEUTICALS INC3,417,0753,417,07508,4745,8771.28%-2,597
10X GENOMICS INC(TXG)481,770481,770010,8786,9181.50%-3,960
SNOWFLAKE INC(SNOW)108,30439,007-69,29712,4406,0231.31%-6,417
BIOAGE LABS INC(BIOA)1,086,353786,353-300,00022,5964,5530.99%-18,043
Page 1 of 1